[1]
A. Luiza Chieffi and I. de Lelis Andrade Morais, “Health risk assessment as a tool for inspection of drug manufacturers and active pharmaceutical ingredients”, Bepa, vol. 13, no. 153/154, pp. 37–43, Mar. 2023.